Platelet-rich plasma (PRP) therapy has moved from the margins of sports medicine into mainstream clinical practice. Athletes at every level, from weekend warriors to professional competitors, are turning to PRP to accelerate recovery from tendon injuries, ligament tears, and chronic joint pain. Understanding what PRP actually does, and what the evidence says about it, helps you make an informed decision before committing to treatment.
Understanding PRP Therapy
PRP is a concentration of platelets derived from your own blood. Platelets are best known for their role in clotting, but they also carry growth factors: proteins that signal tissue repair and cellular regeneration. When platelets are concentrated and injected directly into an injured site, the theory is that these growth factors amplify the body’s natural healing response. ( 1 )
The procedure begins with a standard blood draw. That blood is then placed in a centrifuge, which separates it into layers: red blood cells at the bottom, platelet-poor plasma in the middle, and platelet-rich plasma at the top. The PRP layer is extracted and prepared for injection. The entire process typically takes under an hour and is performed in a clinical setting.
PRP is classified as an autologous treatment, meaning it uses your own biological material. This significantly reduces the risk of immune reaction or rejection compared to synthetic treatments. ( 2 )
How PRP Works: The Science
Growth factors within platelets include platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF). Each plays a role in different stages of tissue repair: cellular proliferation, collagen synthesis, and angiogenesis (new blood vessel formation). ( 3 )
When injected into damaged tissue, PRP creates a concentrated signaling environment. The idea is not to introduce foreign material but to supercharge the healing cascade that would naturally occur, only more slowly. Research published in the American Journal of Sports Medicine found that PRP injections into chronic patellar tendinopathy showed statistically significant improvements in pain and function at 12-week follow-up compared to controls. ( 4 )
The platelet concentration in PRP preparations typically exceeds baseline whole blood levels by a meaningful margin, though exact concentrations vary by preparation method and equipment used. According to a review in Sports Health: A Multidisciplinary Approach, variability in platelet concentration between commercial PRP systems is a key reason why study results across different clinics can differ. ( 5 )
Hormonal environment also plays a role in recovery capacity. Men with suboptimal testosterone levels may find tissue repair slower overall. If you’ve been dealing with persistent injury or poor recovery, it may be worth reviewing what low testosterone looks like and whether it could be a contributing factor.
Benefits and What to Expect
PRP has shown the most consistent evidence in treating tendinopathies, particularly lateral epicondylitis (tennis elbow) and patellar tendinopathy. A 2014 meta-analysis in the British Journal of Sports Medicine found PRP superior to corticosteroid injections for lateral epicondylitis at medium-term follow-up. ( 6 )
For ligament injuries and osteoarthritis, the evidence is more mixed but still promising. A randomized controlled trial published in the Journal of the American Medical Association found that PRP injections for knee osteoarthritis provided greater pain reduction and functional improvement at one year compared to hyaluronic acid injections. ( 7 )
Recovery timelines vary by injury type and severity. Most patients do not experience immediate relief; the growth factor signaling takes days to weeks to produce measurable tissue changes. Clinicians typically recommend a series of injections spaced several weeks apart, based on individual response and injury characteristics.
Side effects are generally mild and localized: temporary soreness at the injection site, minor swelling, and bruising. Systemic side effects are rare given the autologous nature of the treatment. ( 8 )
Common Myths and Misconceptions
Myth: PRP is a quick fix
PRP accelerates a biological process; it does not bypass it. Most patients require multiple sessions and should expect a recovery arc of weeks to months rather than days. Skipping rehabilitation exercises or returning to full activity too soon undermines the treatment’s effectiveness.
Myth: PRP works equally well for all injuries
Evidence strength varies considerably by condition. PRP has stronger support for tendinopathy than for muscle tears or bone stress injuries. Discussing your specific diagnosis with an orthopedic specialist is essential before assuming PRP is appropriate for your injury type.
Myth: More PRP injections always produce better results
A systematic review published in Orthopaedic Journal of Sports Medicine noted that beyond a certain point, additional injections did not consistently improve outcomes and may introduce unnecessary procedural risk. Treatment protocols should be individualized and evidence-guided. ( 9 )
When to See a Doctor
PRP is not a first-line treatment for most sports injuries. Standard care protocols, including rest, physiotherapy, anti-inflammatory management, and graduated return to activity, should be attempted first. PRP becomes relevant when conservative management has failed over a defined period, typically several weeks to months depending on the injury.
Seek evaluation from a sports medicine physician or orthopedic specialist if you have: a tendon injury that has not improved with 6 to 12 weeks of physical therapy; chronic joint pain affecting athletic performance; a diagnosis of mild to moderate osteoarthritis where you want to avoid or delay surgical intervention.
PRP is not appropriate for complete tendon or ligament ruptures requiring surgical repair, active infections at the injection site, or patients with certain blood disorders. A thorough clinical assessment is required before proceeding. ( 10 )
Exploring Your Recovery Options
PRP is one piece of a broader recovery picture. For men dealing with persistent injury, suboptimal healing, or performance decline, the full picture often includes hormonal health, nutrition, and structured rehabilitation. If you’re curious about how hormone optimization fits into long-term athletic recovery, explore our overview of testosterone replacement therapy and what it may offer in a clinical context.
If you’re considering PRP or other regenerative treatments, speak with a qualified sports medicine provider who can assess whether your injury profile, health history, and recovery goals align with what the current evidence supports.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Marx RE. Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery. 2004;62(4):489–496. https://doi.org/10.1016/j.joms.2003.12.003
- Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thrombosis and Haemostasis. 2004;91(1):4–15. https://doi.org/10.1160/TH03-07-0440
- Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from basic science to clinical applications. American Journal of Sports Medicine. 2009;37(11):2259–2272. https://doi.org/10.1177/0363546509349921
- Filardo G, Kon E, Della Villa S, et al. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. International Orthopaedics. 2010;34(6):909–915. https://doi.org/10.1007/s00264-009-0845-7
- Wasterlain AS, Braun HJ, Dragoo JL. Contents and formulations of platelet-rich plasma. Operative Techniques in Orthopaedics. 2012;22(1):33–42. https://doi.org/10.1053/j.oto.2011.11.001
- Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. American Journal of Sports Medicine. 2011;39(6):1200–1208. https://doi.org/10.1177/0363546510397173
- Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Anitua) versus Durolane hyaluronic acid in patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29(10):1635–1643. https://doi.org/10.1016/j.arthro.2013.07.264
- Podesta L, Crow SA, Volkmer D, et al. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. American Journal of Sports Medicine. 2013;41(7):1689–1694. https://doi.org/10.1177/0363546513487979
- Moraes VY, Lenza M, Tamaoki MJ, et al. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database of Systematic Reviews. 2014;(4):CD010071. https://doi.org/10.1002/14651858.CD010071.pub3
- DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998–1009. https://doi.org/10.1016/j.arthro.2012.04.148